Addressing the Global Threat of Antimicrobial Resistance (AMR)

Share this article:

As the world's largest manufacturer of antibiotics, Teva is committed to working with industry peers and global health organizations to identify solutions. Our approach to addressing AMR focuses on: Research and science, access, appropriate use, environment

NPS-ALL-NP-00726 November 2022

Find out more

Learn more about Teva’s involvement in the AMR Action Fund
Explore how we’re making an impact through Environmental, Social and Governance (ESG) across Teva in our annual ESG Progress Report
Interested in getting involved in the work that we do? Explore a career at Teva

You might also be interested

Teva Rise: Accelerating Pharma Innovation Globally

Using Antibiotics Wisely. Making Them Responsibly.

An illustration of a person with an open brain, where two small figures use ladders and tools to explore the inside.

Living with Schizophrenia and Tardive Dyskinesia: An Expert Perspective

Taking time to listen: meeting a tardive dyskinesia patient

Taking time to listen: meeting a schizophrenia patient

Taking time to listen: meeting a schizophrenia carer

Teva scientists in Sydney, Australia working in the lab

2024 Healthy Future Report: Creating the Future We Want to See

Neurological Conditions Take So Much: Teva is Working to Give Something Back

little boys hugging smiling

Spreading HOPE: Teva’s Work to Improve Global Access to Medicine

Dr Beatrice Wiafe Addai addressing breast cancer meeting in Ghana

Behind the Numbers: Working to Tackle Breast Cancer in Ghana